Latvija - latviešu - Zāļu valsts aģentūra

eumedica pharmaceuticals gmbh, germany - sulfamethoxazolum, trimethoprimum - sīrups - 40 mg/8 mg/ml

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

stemline therapeutics b.v. - selinexor - multiple mieloma - antineoplastiski līdzekļi - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - krūts audzējs - endokrīnā terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

belpharma s.a. - tasonermin - sarkoma - imunitātes stimulatori, - beromun ir norādīts pieaugušajiem, kā palīglīdzekli, lai operācijas tam atdalot no audzēja, lai novērstu vai aizkavētu amputācija, vai paliatīvo situāciju, irresectable mīksto audu sarkoma ekstremitātes, ko izmanto kopā ar melfalānu, izmantojot vieglas hyperthermic izolētas ekstremitāšu perfūzijas (ilp).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiski līdzekļi - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - multiple mieloma - antineoplastiski līdzekļi - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Latvija - latviešu - Zāļu valsts aģentūra

lmp, sia, latvia - permetrīns - gels - 50 mg/g

Latvija - latviešu - Zāļu valsts aģentūra

lmp, sia, latvia - permetrīns - gels - 40 mg/g

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ceva sante animale - dinotefuran, piriproksifēnu, permetrīns - permetrīns, kombinācijas - suņi - Ārstēšana un profilakse blusu invāzijas (ctenocephalides felis un ctenocephalides canis). Ārstēšanai un profilaksei, ērces invāzijas (rhipicephalus sanguineus, dermacentor reticulatus, ixodes ricinus). profilakses nokošana no smilšu mušas (phlebotomus perniciosus), odi (culex pipiens, aedes aegypti) un stabilu lido (stomoxys calcitrans). attieksmi pret odu (aedes aegypti) un stabili lidot (stomoxys calcitrans) invāzijas.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

atletika mngt, sia - batoniņš